Scandinavian ChemoTech AB (publ)
STO: CMOTEC-B.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stefan Mohan Frick
- Employees
- 3
- Headquarters
- Lund, Sweden
- IPO year
- 2016
- Market cap
- SEK 92.8M
- Website
- https://chemotech.se
Loading CMOTEC-B…
Loading profile data…Frequently asked questions about CMOTEC-B
What does Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) do?
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of...
Where does CMOTEC-B.ST trade?
Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) trades on the Stockholm Stock Exchange.
What sector is CMOTEC-B.ST in?
Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Scandinavian ChemoTech AB (publ)?
Stefan Mohan Frick is the chief executive officer of Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST).
Where is Scandinavian ChemoTech AB (publ) headquartered?
Scandinavian ChemoTech AB (publ) is headquartered in Sweden.
Does CMOTEC-B.ST pay a dividend?
Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CMOTEC-B.ST go public?
Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) completed its initial public offering in 2016.